| #66 |
Phieng Siliphaivanh |
Merck |
3 |
| #66 |
Anthony Boitano |
Magenta Therapeutics |
3 |
| #103 |
Samuel B. Breneman |
Whirlpool |
2 |
| #103 |
Levi A. Garraway |
Dana-Farber Cancer Institute |
2 |
| #103 |
Jackie Papkoff |
Diadexus |
2 |
| #103 |
Tal Zaks |
Modernatx |
2 |
| #103 |
Hoong Chuin Lim |
— |
2 |
| #103 |
John Joseph Leonard |
Toyota |
2 |
| #103 |
Craig Braun |
Dana-Farber Cancer Institute |
2 |
| #103 |
Dmitri Bobilev |
Tesaro |
2 |
| #103 |
Gang Song |
Ford |
2 |
| #103 |
Colin Fredette |
Waters Technologies |
2 |
| #103 |
Osher Perry |
Shipin Systems |
2 |
| #103 |
Gurdial Singh Sanghera |
Abbott |
2 |
| #103 |
Mitchell A. Harris |
The General Hospital |
2 |
| #103 |
Nikolaos Papaioannou |
Pfizer |
2 |
| #103 |
Jungwook Yang |
IBM |
2 |
| #103 |
Chase Spenser Coffman |
Elektrofi |
2 |
| #103 |
Ding An |
Modernatx |
2 |
| #103 |
Xandra O. Breakefield |
The General Hospital |
2 |
| #103 |
Edmund Meng Yeh |
Northwestern University |
2 |
| #103 |
Gregory Thomas Mark |
Markforged |
2 |
| #103 |
Shitong S. Zhu |
Saudi Arabian Oil |
2 |
| #103 |
Karen Daniel |
Taris Biomedical |
2 |
| #103 |
Anthony D. Amicangioli |
Hyannis Port Research |
2 |
| #103 |
Zhen Huang |
Cambrian Innovation |
2 |
| #103 |
Juejun Hu |
MIT |
2 |
| #103 |
Dedong Wu |
Astrazeneca Ab |
2 |
| #103 |
Michal Aleksander Karczmarek |
Oracle |
2 |
| #103 |
Stephen P. Klaus |
Gcp Applied Technologies |
2 |
| #103 |
Kristen Mulherin |
Advanced Functional Fabrics Of America |
2 |
| #103 |
Christopher J. Eng |
Veracode |
2 |
| #103 |
Robert Ng |
Akouos |
2 |
| #103 |
Adam Looker |
Vertex Pharmaceuticals Incorporated |
2 |
| #103 |
Paula T. Hammond |
MIT |
2 |
| #103 |
Joseph B. Bernstein |
MIT |
2 |
| #103 |
David A. Scott |
Dana-Farber Cancer Institute |
2 |
| #103 |
James Tendai Mutamba |
Monash University |
2 |
| #103 |
Takashi Nakai |
Cyclerion Therapeutics |
2 |
| #103 |
Tuotuo Li |
Intel |
2 |
| #103 |
Doron Levari |
Ignite Scalarc Solutions |
2 |
| #103 |
David Wu |
Sharkninja Operating |
2 |
| #103 |
Denise E. Freed |
Schlumberger Technology |
2 |
| #103 |
Thomas A. Cerruti |
Monsanto Technology |
2 |
| #103 |
Chi-Li Chen |
Tetraphase Pharmaceuticals |
2 |
| #103 |
Leonardus H. T. Van Der Ploeg |
Merck |
2 |
| #103 |
Giovani D. Diniz |
— |
2 |
| #103 |
Alexander Kesler |
Fortifyiq |
2 |
| #103 |
Seth N. Green |
Bose |
2 |
| #103 |
Jeffrey N. Agar |
Brandeis University |
2 |